FDA to Regulate E-Cigarettes, Ban Sales to Minors
May 05 2016 - 10:00AM
Dow Jones News
By Tripp Mickle
The U.S. government on Thursday said it was assuming regulatory
authority over e-cigarettes and all other tobacco products with
rules that will prohibit sales to anyone under 18 and require
manufacturers to submit products for approval.
The Food and Drug Administration rules have the potential to
upend the $3.5 billion e-cig industry. Many of the small vape
shops, device manufacturers and liquid nicotine producers won't be
able to afford the FDA's approval process, which could cost
anywhere from $2 million to $10 million per item, according to the
regulatory consulting company SciLucent LLC.
The approval process is expected to be less damaging for major
tobacco companies that have launched e-cigarette brands, such as
Altria Group Inc., Reynolds American Inc., and Imperial Brands PLC.
Those companies have financial resources to cover the costs that
many small vape shops and liquid nicotine manufacturers lack.
In addition to product approval, the new rules prohibit sales of
ecigs to anyone under 18, health warnings on packages and a ban on
vending-machine sales. The health warnings will say, "WARNING: This
product contains nicotine. Nicotine is an addictive chemical."
"This is going to be a grim day in the history of tobacco-harm
reduction, " said Greg Conley, president of the American Vaping
Association, an industry-funded advocacy group. "It will be a day
where thousands of small businesses will be contemplating whether
they will continue to stay in business and employ people."
In addition to e-cigs, the FDA said it would be taking
regulatory authority over other unregulated tobacco products,
including cigars, pipe tobacco and water pipe tobacco.
Write to Tripp Mickle at Tripp.Mickle@wsj.com
(END) Dow Jones Newswires
May 05, 2016 09:45 ET (13:45 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Altria (NYSE:MO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Altria (NYSE:MO)
Historical Stock Chart
From Apr 2023 to Apr 2024